Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF-macrophage pathway
Proceedings of the National Academy of Sciences · 06.02.2024 · 121 (6)
DOI: 10.1073/pnas.2305947121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 30.01.2024. Verfasst von Wei Yi und 14 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and …. Hauptthemen laut MEDLINE: Optic Nerve Injuries, Mesenchymal Stem Cells, Extracellular Vesicles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Key Research and Development Program of China (NKPs), MOST | National Natural Science Foundation of China (NSFC), Bureau of Science and Information Technology of Guangzhou Municipality | Guangzhou Municipal Science and Technology Project (Guangzhou Science and Technology P….
Abstract (Originalsprache)
Optic neuropathies, characterized by injury of retinal ganglion cell (RGC) axons of the optic nerve, cause incurable blindness worldwide. Mesenchymal stem cell–derived small extracellular vesicles (MSC-sEVs) represent a promising “cell-free” therapy for regenerative medicine; however, the therapeutic effect on neural restoration fluctuates, and the underlying mechanism is poorly understood. Here, we illustrated that intraocular administration of MSC-sEVs promoted both RGC survival and axon regeneration in an optic nerve crush mouse model. Mechanistically, MSC-sEVs primarily targeted retinal mural cells to release high levels of colony-stimulating factor 3 (G-CSF) that recruited a neural restorative population of Ly6C low monocytes/monocyte-derived macrophages (Mo/MΦ). Intravitreal administration of G-CSF, a clinically proven agent for treating neutropenia, or donor Ly6C low Mo/MΦ markedly improved neurological outcomes in vivo. Together, our data define a unique mechanism of MSC-sEV-induced G-CSF-to-Ly6C low Mo/MΦ signaling in repairing optic nerve injury and highlight local delivery of MSC-sEVs, G-CSF, and Ly6C low Mo/MΦ as therapeutic paradigms for the treatment of optic neuropathies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou 510060, People's Republic of China.
- Department of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD 21287.
- Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 17165, Stockholm, Sweden.
ORCID-Profile: Wei Yi, Ying Xue, Wenjie Qing, Yingxue Cao, Lingli Zhou, Mingming Xu, Zehui Sun, Yuying Li, Xiaomei Mai, Le Shi, Chang He, Feng Zhang, Elia J Duh, Yihai Cao, Xialin Liu
Förderung
- MOST | National Key Research and Development Program of China (NKPs)
- MOST | National Natural Science Foundation of China (NSFC)
- Bureau of Science and Information Technology of Guangzhou Municipality | Guangzhou Municipal Science and Technology Project (Guangzhou Science and Technology P…
- Guangdong Provincial Department of Science and Technology (GDSTC)
- Bureau of Science and Information Technology of Guangzhou Municipality | Guangzhou Municipal Science and Technology Project
Zitieren
APA
Yi, W., Xue, Y., Qing, W., Cao, Y., Zhou, L., Xu, M., Sun, Z., Li, Y., Mai, X., Shi, L., He, C., Zhang, F., Duh, E. J., Cao, Y., & Liu, X. (2024). Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF-macrophage pathway. Proceedings of the National Academy of Sciences, 121(6). https://doi.org/10.1073/pnas.2305947121
Vancouver
Yi W, Xue Y, Qing W, Cao Y, Zhou L, Xu M, et al. Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF-macrophage pathway. Proceedings of the National Academy of Sciences. 2024;121(6). doi:10.1073/pnas.2305947121
BibTeX
@article{Yi2024,
author = {Yi, Wei and Xue, Ying and Qing, Wenjie and Cao, Yingxue and Zhou, Lingli and Xu, Mingming and Sun, Zehui and Li, Yuying and Mai, Xiaomei and Shi, Le and He, Chang and Zhang, Feng and Duh, Elia J and Cao, Yihai and Liu, Xialin},
title = {Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF-macrophage pathway},
journal = {Proceedings of the National Academy of Sciences},
year = {2024},
volume = {121},
number = {6},
doi = {10.1073/pnas.2305947121}
}
EUVIMED